AACR
International LAGENO-BC Consortium Spurring Breast Cancer Genetics Research Across Latin America
Premium
The consortium, which includes 13 studies in seven countries, was formed to support breast cancer genetic research across Latin American and Hispanic populations.
Novartis Enters KRAS G12C Space With Positive Phase I/II Data in Lung, Colorectal Cancer
Novartis' JDQ443 showed a 45 percent response rate in advanced KRAS G12C-mutant non-small cell lung cancer patients.
Preclinical Data In Hand, City of Hope to Study Anti-TAG72 CAR T-Cell Therapy for Ovarian Cancer
At AACR, researchers described plans for an upcoming trial of an autologous CAR T-cell therapy infused directly into the peritoneal cavity of epithelial ovarian cancer patients.
Mustang Bio to Study CAR T-Cell, Oncolytic Virus Combination for Recurrent Brain Cancer Patients
The firm will launch a Phase I trial of the C134 oncolytic virus MB-108 followed by the autologous 13Rα2-targeted CAR T-Cell therapy MB-101 for advanced glioblastoma.
At the AACR annual meeting, both companies shared new data on their technologies' performance in detecting early and late-stage cancers.